Background
Introduction
Primary percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI) results in better coronary reperfusion rates and improved clinical outcomes than fibrinolytic therapy. 1 infarct size and left ventricular ejection fraction at follow-up were virtually the same in both arms. 6, 7 Because of these conflicting findings, we additionally performed a reevaluation of our angiographic outcomes by a blinded independent core lab.
Methods

Participants and study protocol
The PREPARE is a multicenter, randomized open trial. Patients with STEMI were randomly assigned in the catheterization laboratory to receive primary PCI with combined proximal embolic protection and thrombus aspiration with the Proxis system or primary PCI alone. The Proxis system is a single-operator full length flexible catheter (6F and 7F guiding catheter compatible) and based on a carbon dioxide gas (CO 2 ) inflation system. It was deployed proximal to the target lesion before crossing.
Inflation of the sealing balloon suspends antegrade flow during the period of lesion intervention. Stagnated blood and emboli, liberated during each intervention were retrieved by aspiration. Crossing of the coronary occlusion with the wire, balloon dilatation, and stent placement were performed through the Proxis system and carried out under full proximal blockade of the vessel. Aspiration and embolic protection by temporary proximal vessel occlusion were repeated during each step of the PCI procedure. 8 In all patients, primary PCI was performed according to current guidelines.
Briefly, consecutive patients aged 18 years or older were eligible for enrolment if In addition, all included patients were asked to participate in an ancillary cardiovascular magnetic resonance (CMR) imaging study. In this study, Proxis-treated patients (n=96) and control patients (n=110) underwent late gadolinium enhancement CMR examination at four to six months after the index procedure.
6
Angiographic analysis and quantitative blush evaluation
At the end of PCI, a coronary angiogram was obtained. All coronary angiograms were re-evaluated by the core lab (YLG and FZ) blinded for treatment allocation and clinical data. On the post-procedural angiogram TIMI-graded flow, myocardial blush grade, and angiographic signs of distal embolization were assessed. Distal embolization was defined as a filling defect, with an abrupt cut-off in the vessel located distally from the infarct-related coronary lesion. 9 The assessment of myocardial blush grade was performed according to van 
Results
Patient and procedural characteristics
Between March 1, 2006, and June 27, 2008, 284 patients, at two centers in the Netherlands and Canada were randomly assigned to receive PCI with combined proximal embolic protection and thrombus aspiration (n=141) or PCI alone (n=143). Figure 1 shows the trial profile. Table 1 shows the baseline and procedural characteristics of the study participants. The proportion of smokers was higher in the control group and patients in the Proxis-treated group were significantly older. Most patients had TIMI grade flow 0 to 1 prior to PCI (98%). The Proxis system could be placed effectively in 94% of the patients. 
Angiographic outcomes and QuBE score
Angiographic outcomes are listed in Table 2 . There were no differences in TIMI-graded flow between primary PCI with combined proximal embolic protection and thrombus aspiration and primary PCI alone (TIMI 3 flow; 92% vs. 88%, p=0.19, respectively). In 229 of the 284 study participants (81%), the QuBE value could be assessed.
Angiograms were excluded for QuBE analysis due to absence of a suitable angiographic run with adequate visualization of the distal coronary and myocardial territory of the infarct-related artery (n=23), too much diaphragm or panning movement (n=27), or major overlap of a non-infarct-related artery (n=5). The mean (±SD) QuBE value was 15.1±5.4 in patients randomized to PCI with combined proximal embolic protection and thrombus aspiration and 15.8±5.5 in patients randomized to PCI alone. The difference in QuBE score among groups was not significant (p=0.34). 
Discussion
This prospective randomized controlled trial demonstrates that combined proximal embolic protection and thrombus aspiration did not improve myocardial perfusion in indices of angiographic outcomes or computer-assisted myocardial blush in patients with STEMI. Despite the fact that Proxis-treated patients had significantly more STsegment resolution immediately after PCI, combined proximal embolic protection and thrombus aspiration did not enhance core-lab adjudicated angiographic outcomes.
Consistent with the findings on angiographic outcomes, the area of late gadolinium enhancement on CMR, left ventricular ejection fraction, and segmental myocardial function did not reveal any beneficial effect of the Proxis system. 6 Multiple explanations exist for why combined proximal embolic protection and thrombus aspiration resulted in conflicting data on continuous ST Holter parameters (ST-segment resolution and ECG injury current over time), angiographic outcomes, infarct size and clinical outcome in this study. First, it appears that the benefit shown from preventing embolization, procedural myocardial infarction and clinical outcome in saphenous venous grafts interventions 12 has not translated into a benefit for preventing distal embolization during primary PCI. 3, 13 It is more likely that the distal embolization during primary PCI that can be prevented by protection devices exerts only minor effects compared with the consequences of ischemic microvascular damage or spontaneous distal embolization arising from ruptured or eroded plaques during the natural course of an acute coronary syndrome. 14 Although the TAPAS study showed a significant reduction in one-year mortality, 5 previous trials of thrombectomy devices have shown conflicting findings, 3, 13, 15 and the method of mechanical thrombectomy may play a significant role in its clinical benefit. Second, patients with a STEMI related to an ostial coronary artery occlusion were not included in the PREPARE study, because of the necessity of a "landing zone" for the Proxis system. For this reason, patients with very proximal infarct-related left anterior descending artery (LAD) and left circumflex artery (LCx) lesions were not included and more patients with a right coronary artery related myocardial infarction (60%) were prevalent in our study. Subsequently, the smaller myocardial infarctions may have attenuated the effect size that might have been seen in proximal LAD and LCx lesions with larger amounts of myocardium at risk. And third, our trial is a proof-of-concept study and was powered to demonstrate benefits in the occurrence of complete STsegment resolution, and not in terms of angiographic or clinical outcomes.
Our study has several limitations. The study reflects a multi-center experience in a relative limited number of patients and represents a mechanical attempt at optimizing myocardial reperfusion in patients undergoing primary PCI. Although one of the largest trials of its kind performed to date, the present study was underpowered to detect a difference in clinical outcome with use of the Proxis system. The study was limited to patients with thrombus-containing lesions with TIMI-graded flow 0 to 1 and did not include the entire acute myocardial infarction population.
Conclusion
Primary PCI with combined proximal embolic protection and thrombus aspiration in STEMI patients resulted more frequently in complete immediate ST-resolution compared to control patients. However, there were no significant differences in core laboratory adjudicated angiographic outcomes.
